Lipid and apolipoprotein levels and distribution in patients with hypertriglyceridemia: effect of triglyceride reductions with atorvastatin (Q73484110)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690940%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Lipid and apolipoprotein levels and distribution in patients with hypertriglyceridemia: effect of triglyceride reductions with atorvastatin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690940%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

N A Le

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690940%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

W Innis-Whitehouse

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690940%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

X Li

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690940%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

R Bakker-Arkema

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690940%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

D Black

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690940%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

W V Brown

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690940%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 February 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690940%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690940%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690940%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690940%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

167-177

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690940%20AND%20SRC:MED&resulttype=core&format=json

Effects of lovastatin on the levels, structure, and atherogenicity of VLDL in patients with moderate hypertriglyceridemia

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991169-7

Pravastatin therapy in primary moderate hypercholesterolaemia: changes in metabolism of apolipoprotein B-containing lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991169-7

Effect of fibric acid derivatives on blood lipid and lipoprotein levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991169-7

Combination therapy with fluvastatin and niacin in hypercholesterolemia: a preliminary report on safety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991169-7

Combination drug therapy for familial combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991169-7

Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991169-7

Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991169-7

Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991169-7

Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991169-7

Relation between cholesterol ester transfer protein activities and lipoprotein cholesterol in patients with hypercholesterolemia and combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991169-7

Bimodal distribution of cholesteryl ester transfer protein activities in normotriglyceridemic men with low HDL cholesterol concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991169-7

Isolation and characterization of human plasma lipid transfer proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991169-7

Inhibition of cholesterol synthesis by mevinolin stimulates low density lipoprotein receptor activity in human monocyte-derived macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991169-7

Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991169-7

Effects of lovastatin therapy on very-low-density lipoprotein triglyceride metabolism in subjects with combined hyperlipidemia: evidence for reduced assembly and secretion of triglyceride-rich lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991169-7

Fenofibrate reduces plasma cholesteryl ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991169-7

Changes in composition and distribution of LDL subspecies in hypertriglyceridemic and hypercholesterolemic patients during gemfibrozil therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991169-7

Simvastatin-induced decrease in the transfer of cholesterol esters from high density lipoproteins to very low and low density lipoproteins in normolipidemic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2800%2991169-7

10.1016/S0026-0495(00)91169-7

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690940%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference